KRRO
Income statement / Annual
Last year (2025), Korro Bio Inc.'s total revenue was $6.39 M,
an increase of 181.46% from the previous year.
In 2025, Korro Bio Inc.'s net income was -$117.26 M.
See Korro Bio Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$6.39 M |
$2.27 M |
$0.00 |
$0.00 |
$14.07 M |
$36.98 M |
$28.95 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$4.28 M
|
$0.00
|
$0.00
|
$0.00
|
$3.84 M
|
$1.58 M
|
$16.81 M
|
$654.00 K
|
$531.00 K
|
| Gross Profit |
$2.11 M
|
$2.27 M
|
$0.00
|
$0.00
|
$10.23 M
|
$35.40 M
|
$12.13 M
|
-$654.00 K
|
-$531.00 K
|
| Gross Profit Ratio |
0.33
|
1
|
0
|
0
|
0.73
|
0.96
|
0.42
|
0
|
0
|
| Research and Development Expenses |
$65.58 M
|
$63.64 M
|
$57.25 M
|
$42.20 M
|
$59.32 M
|
$36.66 M
|
$18.33 M
|
$11.58 M
|
$11.79 M
|
| General & Administrative Expenses |
$28.16 M
|
$30.55 M
|
$24.03 M
|
$16.80 M
|
$11.69 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$12.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$28.16 M
|
$30.55 M
|
$36.54 M
|
$16.80 M
|
$34.93 M
|
$26.30 M
|
$14.48 M
|
$6.71 M
|
$3.99 M
|
| Other Expenses |
-$4.28 M
|
$0.00
|
-$9.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$89.45 M
|
$94.18 M
|
$84.53 M
|
$59.00 M
|
$94.26 M
|
$62.95 M
|
$32.81 M
|
$18.29 M
|
$15.78 M
|
| Cost And Expenses |
$93.73 M
|
$94.18 M
|
$84.53 M
|
$59.00 M
|
$98.10 M
|
$64.53 M
|
$49.62 M
|
$18.94 M
|
$16.31 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$947.00 K
|
$397.00 K
|
$994.00 K
|
$1.78 M
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$118.00 K
|
$764.00 K
|
$0.00
|
$0.00
|
$106.00 K
|
$174.00 K
|
| Depreciation & Amortization |
$4.28 M
|
$3.57 M
|
$3.63 M
|
$2.51 M
|
$3.84 M
|
$1.58 M
|
$813.00 K
|
$654.00 K
|
$531.00 K
|
| EBITDA |
-$83.06 M |
-$88.35 M |
-$80.90 M |
-$56.49 M |
-$80.07 M |
-$24.90 M |
-$17.93 M |
-$18.41 M |
-$19.53 M |
| EBITDA Ratio |
-12.99
|
-38.9
|
0
|
0
|
-5.69
|
-0.67
|
-0.62
|
0
|
0
|
| Operating Income Ratio |
-13.66
|
-40.47
|
0
|
0
|
-5.97
|
-0.74
|
-0.71
|
0
|
0
|
| Total Other Income/Expenses Net |
-$29.28 M
|
$8.47 M
|
$3.39 M
|
$976.00 K
|
-$640.00 K
|
$1.07 M
|
$1.93 M
|
-$224.00 K
|
-$3.93 M
|
| Income Before Tax |
-$116.62 M
|
-$83.44 M
|
-$81.15 M
|
-$58.02 M
|
-$84.67 M
|
-$26.48 M
|
-$18.75 M
|
-$19.17 M
|
-$20.24 M
|
| Income Before Tax Ratio |
-18.25
|
-36.74
|
0
|
0
|
-6.02
|
-0.72
|
-0.65
|
0
|
0
|
| Income Tax Expense |
$637.00 K
|
$141.00 K
|
$27.00 K
|
$10.00 K
|
$15.00 K
|
$35.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$117.26 M
|
-$83.58 M
|
-$81.17 M
|
-$58.03 M
|
-$84.69 M
|
-$26.51 M
|
-$18.75 M
|
-$19.17 M
|
-$20.24 M
|
| Net Income Ratio |
-18.34
|
-36.8
|
0
|
0
|
-6.02
|
-0.72
|
-0.65
|
0
|
0
|
| EPS |
-12.48 |
-9.37 |
-53.09 |
-227.58 |
-4.94 |
-41.1 |
-30.39 |
-30.57 |
-32.27 |
| EPS Diluted |
-12.48 |
-9.37 |
-53.08 |
-227.42 |
-4.94 |
-41.1 |
-30.39 |
-30.57 |
-32.27 |
| Weighted Average Shares Out |
$9.40 M
|
$8.92 M
|
$1.53 M
|
$255.00 K
|
$4.45 M
|
$645.06 K
|
$616.89 K
|
$627.09 K
|
$627.09 K
|
| Weighted Average Shares Out Diluted |
$9.40 M
|
$8.92 M
|
$1.53 M
|
$255.17 K
|
$4.45 M
|
$645.06 K
|
$616.89 K
|
$627.09 K
|
$627.09 K
|
| Link |
|
|
|
|
|
|
|
|
|
